Thursday, July 29, 2021 Daily Archives

Repligen expanding MA and Ireland sites to support long-term growth

by

Repligen will lease a plant in Hopkington, Massachusetts and build a facility in Waterford, Ireland as part of capacity growth plans. Repligen announced its second quarter 2021 financials this week, reporting sales of $163 million, up 86% year-on-year. Like its bioprocess peers, record revenue – along with significant order intake – relate to a mix of a robust industry sector and the high demand for COVID-19 related vaccine and therapy consumables and services. Also like its bioprocess vendor peers, Repligen…

July 29, 2021

Catalent aims to shorten development timelines through GPEx tech launch

by

Catalent says its GPEx Lightning platform can save up to twelve weeks on customer program timelines by combining multiple technologies into a single process. Contract development manufacturing organization (CDMO) Catalent has created GPEx Lightning, which it says combines gene insertion activities to minimize drug substance development time by up to three months. The tech is based on its long-standing GPEx tech platform. “By adapting the cell line and incorporating some enhancements into the process, we were able to increase the…

July 29, 2021